Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 51 | 2023 | 297 | 9.530 |
Why?
|
| Melatonin | 42 | 2023 | 129 | 7.850 |
Why?
|
| Sleep | 53 | 2024 | 355 | 6.550 |
Why?
|
| Light | 18 | 2017 | 80 | 4.020 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 18 | 2021 | 58 | 3.730 |
Why?
|
| Sleep Wake Disorders | 13 | 2023 | 130 | 3.490 |
Why?
|
| Phototherapy | 10 | 2019 | 36 | 2.710 |
Why?
|
| Photoperiod | 10 | 2016 | 49 | 2.280 |
Why?
|
| Low Back Pain | 4 | 2020 | 121 | 1.880 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2023 | 232 | 1.620 |
Why?
|
| Adult | 56 | 2023 | 8152 | 1.530 |
Why?
|
| Saliva | 15 | 2018 | 60 | 1.490 |
Why?
|
| Chronic Pain | 4 | 2020 | 114 | 1.480 |
Why?
|
| Lighting | 7 | 2016 | 19 | 1.410 |
Why?
|
| Female | 66 | 2023 | 15793 | 1.370 |
Why?
|
| Humans | 88 | 2024 | 28462 | 1.340 |
Why?
|
| Actigraphy | 7 | 2023 | 101 | 1.330 |
Why?
|
| Male | 52 | 2023 | 15367 | 1.100 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 88 | 1.060 |
Why?
|
| Time Factors | 20 | 2018 | 1497 | 1.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2022 | 108 | 0.940 |
Why?
|
| Young Adult | 18 | 2020 | 2100 | 0.930 |
Why?
|
| Wrist | 2 | 2022 | 17 | 0.930 |
Why?
|
| HIV Infections | 4 | 2023 | 486 | 0.910 |
Why?
|
| Sleep Deprivation | 4 | 2012 | 75 | 0.820 |
Why?
|
| Surveys and Questionnaires | 12 | 2019 | 1216 | 0.800 |
Why?
|
| Affect | 5 | 2020 | 63 | 0.750 |
Why?
|
| Chronobiology Disorders | 2 | 2018 | 16 | 0.730 |
Why?
|
| Body Temperature | 9 | 2016 | 50 | 0.720 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 213 | 0.680 |
Why?
|
| Middle Aged | 18 | 2023 | 9306 | 0.670 |
Why?
|
| Receptors, Melatonin | 2 | 2018 | 3 | 0.660 |
Why?
|
| Wearable Electronic Devices | 2 | 2019 | 44 | 0.650 |
Why?
|
| Wakefulness | 11 | 2016 | 97 | 0.650 |
Why?
|
| Depression | 3 | 2022 | 454 | 0.640 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 81 | 0.620 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 20 | 0.600 |
Why?
|
| Sleep Hygiene | 1 | 2017 | 5 | 0.590 |
Why?
|
| Pain Management | 1 | 2019 | 147 | 0.560 |
Why?
|
| Fibromyalgia | 1 | 2017 | 30 | 0.540 |
Why?
|
| Photic Stimulation | 2 | 2016 | 37 | 0.530 |
Why?
|
| Housing | 1 | 2016 | 19 | 0.510 |
Why?
|
| Migraine Disorders | 3 | 2022 | 19 | 0.510 |
Why?
|
| Central Nervous System Agents | 1 | 2015 | 8 | 0.500 |
Why?
|
| Chronobiology Phenomena | 1 | 2015 | 3 | 0.500 |
Why?
|
| Ethanol | 2 | 2016 | 120 | 0.500 |
Why?
|
| Adolescent | 11 | 2018 | 2324 | 0.500 |
Why?
|
| Acute Pain | 3 | 2020 | 21 | 0.490 |
Why?
|
| Jet Lag Syndrome | 5 | 2021 | 18 | 0.490 |
Why?
|
| Wakefulness-Promoting Agents | 1 | 2014 | 1 | 0.480 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 4 | 0.480 |
Why?
|
| Pilot Projects | 5 | 2019 | 440 | 0.480 |
Why?
|
| Automobile Driving | 1 | 2014 | 20 | 0.470 |
Why?
|
| Occupational Health | 1 | 2014 | 22 | 0.470 |
Why?
|
| Seasons | 1 | 2014 | 24 | 0.470 |
Why?
|
| Motor Skills | 1 | 2014 | 52 | 0.460 |
Why?
|
| Patient Compliance | 2 | 2015 | 165 | 0.460 |
Why?
|
| Catastrophization | 3 | 2019 | 16 | 0.460 |
Why?
|
| Attention | 1 | 2014 | 138 | 0.440 |
Why?
|
| Heart Rate | 4 | 2004 | 115 | 0.430 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 28 | 0.410 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 42 | 0.350 |
Why?
|
| Hypertension | 1 | 2012 | 226 | 0.350 |
Why?
|
| Polysomnography | 4 | 2022 | 85 | 0.340 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 192 | 0.320 |
Why?
|
| Activity Cycles | 1 | 2008 | 3 | 0.310 |
Why?
|
| Pain Threshold | 2 | 2019 | 21 | 0.300 |
Why?
|
| Shift Work Schedule | 2 | 2018 | 9 | 0.300 |
Why?
|
| Arousal | 2 | 2005 | 50 | 0.300 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 13 | 0.300 |
Why?
|
| Veterans | 2 | 2020 | 93 | 0.300 |
Why?
|
| Heart | 2 | 2005 | 66 | 0.290 |
Why?
|
| tau Proteins | 1 | 2008 | 239 | 0.280 |
Why?
|
| Social Support | 2 | 2018 | 216 | 0.280 |
Why?
|
| Autonomic Nervous System | 2 | 2004 | 19 | 0.270 |
Why?
|
| Adaptation, Physiological | 2 | 2005 | 53 | 0.260 |
Why?
|
| Quality of Life | 2 | 2022 | 660 | 0.260 |
Why?
|
| Parasympathetic Nervous System | 1 | 2005 | 2 | 0.250 |
Why?
|
| Self Report | 2 | 2017 | 226 | 0.250 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 13 | 0.250 |
Why?
|
| Endotoxemia | 2 | 2015 | 27 | 0.240 |
Why?
|
| Intestinal Absorption | 2 | 2015 | 37 | 0.240 |
Why?
|
| Cell Membrane Permeability | 2 | 2015 | 58 | 0.240 |
Why?
|
| Anxiety | 3 | 2022 | 161 | 0.240 |
Why?
|
| Seasonal Affective Disorder | 1 | 2004 | 3 | 0.230 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 2 | 0.230 |
Why?
|
| Darkness | 3 | 2010 | 18 | 0.220 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 939 | 0.210 |
Why?
|
| Kynurenine | 1 | 2022 | 1 | 0.210 |
Why?
|
| Neurotic Disorders | 1 | 2002 | 19 | 0.210 |
Why?
|
| Pain Measurement | 3 | 2020 | 473 | 0.200 |
Why?
|
| Biomarkers | 3 | 2016 | 601 | 0.200 |
Why?
|
| Critical Care | 1 | 2024 | 197 | 0.190 |
Why?
|
| Intensive Care Units | 1 | 2024 | 295 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 184 | 0.180 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 36 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2001 | 57 | 0.180 |
Why?
|
| Volatilization | 1 | 2020 | 3 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 373 | 0.160 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 166 | 0.160 |
Why?
|
| Military Personnel | 1 | 2019 | 40 | 0.160 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2016 | 11 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 349 | 0.150 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 22 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 14 | 0.150 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2016 | 22 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2018 | 93 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2020 | 3619 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 159 | 0.140 |
Why?
|
| Fluoxetine | 1 | 2017 | 34 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2015 | 44 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2017 | 111 | 0.140 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 97 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 102 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 44 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2016 | 34 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2008 | 466 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2016 | 110 | 0.130 |
Why?
|
| United States | 2 | 2019 | 2185 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 129 | 0.120 |
Why?
|
| Colon | 1 | 2016 | 145 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2015 | 66 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 23 | 0.120 |
Why?
|
| Occupations | 1 | 2014 | 18 | 0.120 |
Why?
|
| Linear Models | 1 | 2015 | 255 | 0.120 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 17 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 2421 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2015 | 276 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 196 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 1391 | 0.110 |
Why?
|
| Sleep Stages | 2 | 2012 | 26 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 311 | 0.110 |
Why?
|
| Liver | 1 | 2014 | 160 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 321 | 0.110 |
Why?
|
| Biological Clocks | 2 | 2011 | 17 | 0.110 |
Why?
|
| HIV | 2 | 2023 | 43 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 726 | 0.100 |
Why?
|
| Sleep, REM | 2 | 2004 | 15 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3612 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2004 | 204 | 0.090 |
Why?
|
| Sex Factors | 2 | 2017 | 480 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2010 | 63 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 9339 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cognition | 3 | 2023 | 1371 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 424 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2020 | 233 | 0.080 |
Why?
|
| Kinetics | 1 | 2008 | 185 | 0.080 |
Why?
|
| Reference Values | 1 | 2008 | 199 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 992 | 0.070 |
Why?
|
| Child | 3 | 2015 | 1423 | 0.060 |
Why?
|
| Permeability | 2 | 2016 | 119 | 0.060 |
Why?
|
| Antioxidants | 1 | 2005 | 65 | 0.060 |
Why?
|
| Aviation | 1 | 2005 | 5 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2005 | 98 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 83 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 55 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2003 | 60 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2003 | 5 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 18 | 0.050 |
Why?
|
| Rest | 1 | 2003 | 33 | 0.050 |
Why?
|
| Family | 1 | 2024 | 111 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2022 | 4 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 10 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 38 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 73 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2002 | 11 | 0.050 |
Why?
|
| Sports | 1 | 2003 | 60 | 0.050 |
Why?
|
| Overweight | 1 | 2023 | 77 | 0.050 |
Why?
|
| Amygdala | 1 | 2022 | 43 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 34 | 0.050 |
Why?
|
| Psychotherapy | 1 | 2022 | 43 | 0.050 |
Why?
|
| Arrhythmia, Sinus | 1 | 2001 | 2 | 0.050 |
Why?
|
| Respiration | 1 | 2001 | 35 | 0.050 |
Why?
|
| Rectum | 1 | 2001 | 45 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 260 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 171 | 0.050 |
Why?
|
| Foot | 1 | 2001 | 45 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2001 | 109 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 12 | 0.040 |
Why?
|
| Yoga | 1 | 2020 | 12 | 0.040 |
Why?
|
| Obesity | 1 | 2023 | 322 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 68 | 0.040 |
Why?
|
| Mindfulness | 1 | 2020 | 48 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 75 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 82 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2018 | 53 | 0.040 |
Why?
|
| Psychology | 1 | 2018 | 24 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 28 | 0.040 |
Why?
|
| Mice | 2 | 2014 | 1467 | 0.040 |
Why?
|
| Genes | 1 | 2018 | 6 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 8 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 502 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4904 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 442 | 0.040 |
Why?
|
| Emotions | 1 | 2018 | 87 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 59 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 259 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 329 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 183 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 340 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 65 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 382 | 0.030 |
Why?
|
| Sleep Medicine Specialty | 1 | 2015 | 3 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 68 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 243 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2015 | 9 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2015 | 36 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 941 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 40 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 69 | 0.030 |
Why?
|
| Animals | 2 | 2014 | 3798 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 20 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 103 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 115 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 279 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 107 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 102 | 0.030 |
Why?
|
| Cues | 1 | 2013 | 50 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 612 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2014 | 692 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 628 | 0.020 |
Why?
|
| Schools | 1 | 2011 | 46 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 600 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 69 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 98 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2011 | 41 | 0.020 |
Why?
|
| Circadian Clocks | 1 | 2011 | 32 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 64 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1810 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 7 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 494 | 0.020 |
Why?
|
| MMPI | 1 | 2005 | 6 | 0.020 |
Why?
|
| Time | 1 | 2005 | 15 | 0.020 |
Why?
|
| Personality | 1 | 2005 | 56 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 208 | 0.010 |
Why?
|
| Reaction Time | 1 | 2003 | 114 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 64 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2002 | 80 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 1254 | 0.010 |
Why?
|